Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice-Reference-Cited by-同舟云学术

Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice

Published:2019-06-01 Issue:6 Volume:4 Page:564
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Chau Katherine Hsin-Yu¹²,Kennedy Kevin F.³,Messenger John C.⁴,Garratt Kirk N.⁵,Maddox Thomas M.⁶,Yeh Robert W.⁷,Kirtane Ajay J.¹²⁸

Affiliation:

1. Herbert and Sandi Feinberg Interventional Cardiology and Heart Valve Center at Columbia University Medical Center/New York–Presbyterian Hospital, New York

2. Cardiovascular Research Foundation, New York, New York

3. Mid America Heart Institute, Kansas City, Missouri

4. Division of Cardiology, University of Colorado School of Medicine, Aurora

5. Center for Heart and Vascular Health, Christiana Care Health System, Newark, Delaware

6. Division of Cardiology, Washington University School of Medicine in St Louis, St Louis, Missouri

7. Department of Medicine, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

8. Associate Editor, JAMA Cardiology

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

http:///jamacardiology/article-pdf/4/6/564/17664450/jamacardiology_chau_2019_br_190003.pdf

Reference15 articles.

1. Continued High Rates of IVC Filter Use After US Food and Drug Safety Warning.;Redberg;JAMA Intern Med,2017

2. Everolimus-eluting bioresorbable scaffolds for coronary artery disease.;Ellis;N Engl J Med,2015

3. 1-Year outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: a propensity-matched comparison of the GHOST-EU and XIENCE V USA registries.;Tamburino;JACC Cardiovasc Interv,2016

4. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.;Serruys;Lancet,2016

5. 3-Year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial.;Kereiakes;J Am Coll Cardiol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Bioresorbable metallic stents:Advancements and future perspectives;Journal of Cardiology;2024-08

2. Fatigue strength and life prediction of lower limb venous stents under three-stage loading conditions;Computer Methods in Biomechanics and Biomedical Engineering;2023-08-21